Skip to main content
. 2014 Aug 6;5(18):8429–8441. doi: 10.18632/oncotarget.2316

Table 1. Relationship of the Expression of ISG15 and Clinicopathological Feature of HCC.

Parameter Groups Number of Patient ISG15 Relative Expression P
Age(yr) ≥50 19 0.92±0.14 0.764
<50 31 0.84±0.09
Gender Male 44 0.85±0.08 0.456
Female 6 0.86±0.22
HBV infection Postive 46 0.89±0.08 0.555
Negative 4 1.07±0.38
AFP(ng/ml) ≥400 27 0.87±0.11 0.394
<400 23 0.93±0.12
Tumor size(cm) ≥5 29 0.88±0.12 0.680
<5 21 0.84±0.09
Tumor number Single 39 0.86±0.09 0.210
Multiple 11 1.22±0.13
Differentiation Moderate to well 33 0.54±0.06 <0.001*
Poor 17 1.34±0.20
Portal vein tumor thrombus Positive 3 1.01±0.40 0.685
Negative 47 0.86±0.08
Metastasis Positive 22 1.12±0.10 0.001*
Negative 28 0.68±0.11